SCHEMBL6711112

SCHEMBL6711112

CC([C]=O)(C#N)c1cccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
ALDH1A1 P00352 4/20 0.36
CYP2A6 P11509 2/20 0.36
ACP3 P15309 2/20 0.36
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CA9 Q16790 1/20 0.35
HSP90AA1 P07900 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MCL1 Q07820 1/20 0.33
SSTR4 P31391 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5644819 0.79 ALDH1A1 (0.40) CA1CA2ALDH1A1CYP2A6ACP3
SCHEMBL3223599 0.79 ALDH1A1 (0.40) CA1CA2ALDH1A1CYP2A6ACP3
SCHEMBL27614634 0.76 CA1 (0.40) CA1CA2ALDH1A1CYP2A6ACP3
Formaldehyde SCHEMBL28441436 0.75 KIF11 (0.44) CA1CA2ALDH1A1CYP2A6ACP3
SCHEMBL4770081 0.72 ALDH1A1 (0.44) CA1CA2ALDH1A1CYP2A6ACP3
SCHEMBL8377365 0.72 ALDH1A1 (0.44) CA1CA2ALDH1A1CYP2A6ACP3
SCHEMBL7338740 0.72 KDM4E (0.42) CA1CA2ALDH1A1ACP3KDM4E
SCHEMBL7334218 0.72 TDP1 (0.42) ALDH1A1ACP3KDM4EHSD17B10HPGD
SCHEMBL29972825 0.72 KIF11 (0.48) CA1CA2ALDH1A1CYP2A6ACP3
SCHEMBL4818310 0.72 KIF11 (0.48) CA1CA2ALDH1A1CYP2A6ACP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed